203 related articles for article (PubMed ID: 36741231)
21. Prevalence and clinical relevance of 52-kDa and 60-kDa Ro/SS-A autoantibodies in Japanese patients with systemic sclerosis.
Fujimoto M; Shimozuma M; Yazawa N; Kubo M; Ihn H; Sato S; Tamaki T; Kikuchi K; Tamaki K
Ann Rheum Dis; 1997 Nov; 56(11):667-70. PubMed ID: 9462169
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of tests for SS-A/Ro, Ro52 and Ro60 in predicting congenital heart block].
Miyano A; Nakayama M; Waguri M; Nakanishi I
Rinsho Byori; 2014 Apr; 62(4):324-31. PubMed ID: 25022061
[TBL] [Abstract][Full Text] [Related]
23. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
[TBL] [Abstract][Full Text] [Related]
24. Anti-SSA Ro52/Ro60 antibody testing by immunodot could help the diagnosis of Sjogren's syndrome in the absence of anti-SSA/SSB antibodies by ELISA.
Mekinian A; Nicaise-Roland P; Chollet-Martin S; Fain O; Crestani B
Rheumatology (Oxford); 2013 Dec; 52(12):2223-8. PubMed ID: 24026249
[TBL] [Abstract][Full Text] [Related]
25. Common and specific associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies in systemic lupus erythematosus.
Menéndez A; Gómez J; Caminal-Montero L; Díaz-López JB; Cabezas-Rodríguez I; Mozo L
ScientificWorldJournal; 2013; 2013():832789. PubMed ID: 24294139
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the anti-Ro/SSA autoantibody profile between patients with primary and secondary Sjögren's syndrome.
Gál I; Lakos G; Zeher M
Autoimmunity; 2000 Sep; 32(2):89-92. PubMed ID: 11078154
[TBL] [Abstract][Full Text] [Related]
27. Anti-Ro52/TRIM21 serological subsets identify differential clinical and laboratory parameters.
Lee AYS; Lin MW; Reed JH
Clin Rheumatol; 2022 Nov; 41(11):3495-3501. PubMed ID: 35871174
[TBL] [Abstract][Full Text] [Related]
28. Ultrasound salivary gland involvement in Sjogren's syndrome vs. other connective tissue diseases: is it autoantibody and gland dependent?
La Paglia GMC; Sanchez-Pernaute O; Alunno A; Martínez-Becerra MJ; Romero-Bueno F; Recuero S; Borges PE; Mahillo-Fernández I; Garrido J; Gerli R; Herrero-Beaumont G; Naredo E
Clin Rheumatol; 2020 Apr; 39(4):1207-1215. PubMed ID: 31676972
[TBL] [Abstract][Full Text] [Related]
29. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
[TBL] [Abstract][Full Text] [Related]
30. Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis.
Gkoutzourelas A; Liaskos C; Mytilinaiou MG; Simopoulou T; Katsiari C; Tsirogianni A; Daoussis D; Scheper T; Meyer W; Bogdanos DP; Sakkas LI
Front Immunol; 2018; 9():2835. PubMed ID: 30581434
[TBL] [Abstract][Full Text] [Related]
31. Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease.
Gunnarsson R; El-Hage F; Aaløkken TM; Reiseter S; Lund MB; Garen T; ; Molberg Ø
Rheumatology (Oxford); 2016 Jan; 55(1):103-8. PubMed ID: 26320136
[TBL] [Abstract][Full Text] [Related]
32. SS-A/Ro antibodies in Chinese patients with systemic lupus erythematosus and Sjögren's syndrome.
Tsay GJ; Wang CL; Chen TY; Huang CN; Hsu TC
J Formos Med Assoc; 1996 Dec; 95(12):905-10. PubMed ID: 9000806
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms of the Ro52 gene associated with anti-Ro 52-kd autoantibodies in patients with primary Sjögren's syndrome.
Nakken B; Jonsson R; Bolstad AI
Arthritis Rheum; 2001 Mar; 44(3):638-46. PubMed ID: 11263778
[TBL] [Abstract][Full Text] [Related]
34. Anti-La positive, anti-Ro negative subset of primary Sjögren's syndrome: anti-La is a reality but is the disease?
Danda D; Sharma R; Truong D; Koelsch KA; Kurien BT; Bagavant H; Deshmukh U; Kaufman CE; Lewis DM; Stone DU; Radfar L; Rasmussen A; Sivils KL; Scofield RH
Clin Exp Rheumatol; 2017; 35(3):438-444. PubMed ID: 28229827
[TBL] [Abstract][Full Text] [Related]
35. Anti-ENA profiles related with anti-SS-A/Ro. The detection of Ro52 and Ro60 according to the presence of SS-B/La, and ANA pattern and titer.
González DA; Rodríguez CC; Armas LM; Varela AR; Rodríguez IM; Duarte MT; de León AC
Immunol Lett; 2014 Sep; 161(1):6-12. PubMed ID: 24768604
[TBL] [Abstract][Full Text] [Related]
36. The prevalence and the clinical relevance of anti-Ro52 in Korean patients with primary Sjögren's syndrome.
Song JS; Do JH; Lee SW
Rheumatol Int; 2012 Feb; 32(2):491-5. PubMed ID: 21246358
[TBL] [Abstract][Full Text] [Related]
37. Reducing the burden of surveillance in pregnant women with no history of fetal atrioventricular block using the negative predictive value of anti-Ro/SSA antibody titers.
Kaizer AM; Lindblade C; Clancy R; Tebo AE; Drewes B; Masson M; Chang M; Fraser N; Buyon JP; Cuneo BF
Am J Obstet Gynecol; 2022 Nov; 227(5):761.e1-761.e10. PubMed ID: 35690080
[TBL] [Abstract][Full Text] [Related]
38. Clinical significances of antibodies to Ro/SS-A autoantigens and its subtypes in primary Sjögren's syndrome.
Cho CS; Park SH; Min JK; Lee SH; Kim HY
Korean J Intern Med; 1997 Jun; 12(2):176-81. PubMed ID: 9439152
[TBL] [Abstract][Full Text] [Related]
39. Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease.
Peene I; Meheus L; De Keyser S; Humbel R; Veys EM; De Keyser F
Ann Rheum Dis; 2002 Oct; 61(10):929-33. PubMed ID: 12228166
[TBL] [Abstract][Full Text] [Related]
40. An updated review of anti-Ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management.
Decker P; Moulinet T; Pontille F; Cravat M; De Carvalho Bittencourt M; Jaussaud R
Autoimmun Rev; 2022 Mar; 21(3):103013. PubMed ID: 34896652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]